Elevating the Quality of Cancer Care via Cross-Department Collaboration

Commentary
Podcast

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

CancerNetwork® visited Sibley Memorial Hospital of Johns Hopkins Medicine to speak with a variety of experts about therapeutic advancements and ongoing research initiatives across several different cancer fields. As part of each discussion, clinicians highlighted how collaboration across different departments has positively affected treatment planning, decision-making, and outcomes at their institution.

These experts included the following:

  • Rachit Kumar, MD, an assistant professor of radiation oncology and molecular radiation sciences at Johns Hopkins School of Medicine and a radiation oncologist specializing in genitourinary and gastrointestinal cancers at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center for Sibley Memorial Hospital and Suburban Hospital;
  • Michael J. Pishvaian, MD, PhD, director of gastrointestinal, developmental therapeutics, and clinical research programs and associate professor of oncology at Johns Hopkins School of Medicine;
  • Nina Wagner-Johnston, MD, a professor of oncology and the director of lymphoma drug development at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, director of Hematologic Malignancies National Capital Region, and codirector of clinical research for hematologic malignancies;
  • Valerie Lee, MD, an assistant professor of oncology at Johns Hopkins University School of Medicine and a medical oncologist at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital;
  • Armine Smith, MD, the director of urologic oncology at the Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and an assistant clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine;
  • Pouneh Razavi, MD, the director for breast imaging in the National Capital Region and an instructor in radiology and radiological science; and
  • Curtiland Deville Jr, MD, medical director of the Johns Hopkins Proton Therapy Center and clinical director of radiation oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital.

Altogether, their insights demonstrated how multidisciplinary teamwork has improved outcomes ranging from patient survival to health care resource utilization across a wide range of diseases, including breast cancer, gastrointestinal cancer, genitourinary cancer, and hematologic malignancies.

Recent Videos
Thomas Hope, MD, believes that an NRC initiative to update infiltration guidelines may organically address concerns that H.R. 2541 outlines.
Thomas Hope, MD, had not observed an adverse effect attributable to an infiltration across more than a decade of administering nuclear agents at UCSF.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Related Content